To date, over 100,000 people nationwide have undergone cancer gene panel testing, but there are still disparities in implementation between facilities and regions. We welcome referrals from local medical institutions so that more patients can benefit from this testing.
The field of cancer chemotherapy is advancing rapidly, and the treatments currently being used are quite different from the image of traditional anti-cancer drug therapy that many patients have. With the advent of molecular targeted therapy and advances in immunotherapy, the number of drugs with fewer side effects is increasing, and drugs that suppress side effects (supportive care) have also made significant advances. While some chemotherapy requires hospitalization, most treatments are performed on an outpatient basis (outpatient chemotherapy). In this environment, it is no longer necessarily difficult for cancer patients to balance their work and life with treatment. We would like to work together to consider how patients can not only focus on their illness, but also enjoy life and live vibrantly.